Memantine Hcl Tablet
NDC 72189-538
Product Information
Memantine Hcl is a ANDA-approved product labeled by Direct_rx. Memantine is used to treat moderate to severe confusion (dementia) related to Alzheimer's disease. It is supplied as a gray tablet for oral administration. This product entry covers the primary NDC 72189-538 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
M10
Code Structure Chart
Product Details
What is NDC 72189-538?
What are the uses of this product?
What are Active Ingredients of this product?
- MEMANTINE HYDROCHLORIDE 10 mg/1 - AMANTADINE derivative that has some dopaminergic effects. It has been proposed as an antiparkinson agent.
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- MEMANTINE HYDROCHLORIDE (UNII: JY0WD0UA60)
- MEMANTINE (UNII: W8O17SJF3T) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)
- POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)
- CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)
- FERROSOFERRIC OXIDE (UNII: XM0M87F357)
- SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- POLYVINYL ALCOHOL, UNSPECIFIED (UNII: 532B59J990)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
- TALC (UNII: 7SEV7J4R1U)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 996561 - memantine HCl 10 MG Oral Tablet
- RxCUI: 996561 - memantine hydrochloride 10 MG Oral Tablet
Which are the Pharmacologic Classes of this product?
* Please review the full disclaimer at the bottom of this page.